Dynamic Advisor Solutions’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$645K Sell
13,464
-5,672
-30% -$244K 0.02% 606
2026
Q1
$703K Sell
19,136
-33,720
-64% -$1.6M 0.02% 552
2025
Q4
$2.69M Buy
52,856
+21,767
+70% +$1.11M 0.09% 242
2025
Q3
$1.73M Buy
31,089
+331
+1% +$19.4K 0.05% 350
2025
Q2
$2.12M Buy
30,758
+6,920
+29% +$471K 0.07% 297
2025
Q1
$1.66M Sell
23,838
-642
-3% -$53K 0.05% 317
2024
Q4
$2.11M Sell
24,480
-2,757
-10% -$298K 0.09% 202
2024
Q3
$3.24M Sell
27,237
-812
-3% -$108K 0.1% 229
2024
Q2
$4M Buy
28,049
+4,927
+21% +$653K 0.13% 193
2024
Q1
$2.97M Sell
23,122
-6,497
-22% -$773K 0.1% 241
2023
Q4
$3.14M Buy
29,619
+296
+1% +$29.3K 0.12% 218
2023
Q3
$2.67M Buy
29,323
+1,685
+6% +$148K 0.13% 191
2023
Q2
$2.24M Buy
27,638
+2,616
+10% +$214K 0.12% 206
2023
Q1
$1.99M Buy
25,022
+20,814
+495% +$1.48M 0.12% 212
2022
Q4
$285K Buy
+4,208
New +$247K 0.02% 564
2022
Q3
Sell
-4,076
Closed -$227K 730
2022
Q2
$227K Buy
4,076
+46
+1% +$2.55K 0.02% 614
2022
Q1
$224K Sell
4,030
-892
-18% -$45.8K 0.02% 649
2021
Q4
$276K Buy
4,922
+150
+3% +$8.13K 0.02% 594
2021
Q3
$229K Buy
+4,772
New +$231K 0.02% 657
2019
Q1
Sell
-17,672
Closed -$410K 445
2018
Q4
$410K Sell
17,672
-4,522
-20% -$100K 0.09% 239
2018
Q3
$523K Sell
22,194
-1,272
-5% -$31K 0.11% 215
2018
Q2
$541K Sell
23,466
-670
-3% -$15.9K 0.12% 199
2018
Q1
$594K Buy
24,136
+1,304
+6% +$34.2K 0.15% 171
2017
Q4
$613K Sell
22,832
-424
-2% -$10.8K 0.2% 135
2017
Q3
$560K Sell
23,256
-260
-1% -$5.88K 0.22% 129
2017
Q2
$504K Sell
23,516
-100
-0.4% -$2.02K 0.2% 136
2017
Q1
$405K Buy
23,616
+200
+0.9% +$3.48K 0.16% 152
2016
Q4
$420K Buy
23,416
+1,740
+8% +$31.5K 0.17% 151
2016
Q3
$451K Buy
21,676
+1,050
+5% +$26K 0.17% 149
2016
Q2
$555K Sell
20,626
-350
-2% -$9.6K 0.22% 119
2016
Q1
$568K Sell
20,976
-378
-2% -$10.1K 0.24% 107
2015
Q4
$620K Buy
21,354
+4
+0% +$111 0.26% 103
2015
Q3
$579K Buy
21,350
+1,344
+7% +$38.1K 0.29% 89
2015
Q2
$548K Sell
20,006
-10,490
-34% -$295K 0.32% 87
2015
Q1
$814K Buy
30,496
+10,516
+53% +$242K 0.41% 72
2014
Q4
$423K Buy
19,980
+1,060
+6% +$23.7K 0.23% 130
2014
Q3
$450K Sell
18,920
-50
-0.3% -$1.15K 0.24% 121
2014
Q2
$438K Sell
18,970
-11,744
-38% -$259K 0.26% 118
2014
Q1
$701K Sell
30,714
-15,436
-33% -$329K 0.48% 72
2013
Q4
$853K Buy
+46,150
New +$804K 0.63% 46

Other funds holding NVO

Dynamic Advisor Solutions's NVO Position: Q2 2026 in Review

Dynamic Advisor Solutions reduced its Novo Nordisk (NVO) stake by 30% in Q2 2026, selling an estimated $244K and leaving 13,464 shares worth $645K. The position accounts for 0.02% of the portfolio, ranked #606.

Dynamic Advisor Solutions first reported a position in NVO in Q4 2013 and has held it in 40 quarters since. The position peaked at $4M in Q2 2024. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Dynamic Advisor Solutions held 13,464 shares of Novo Nordisk worth $645K as of Q2 2026.
  • Dynamic Advisor Solutions sold 5,672 Novo Nordisk shares in Q2 2026, an estimated $244K.
  • Novo Nordisk made up 0.02% of Dynamic Advisor Solutions's portfolio in Q2 2026, its #606 holding.
  • Dynamic Advisor Solutions first reported a position in Novo Nordisk in Q4 2013 and has held it in 40 quarters since.
  • Dynamic Advisor Solutions's Novo Nordisk position peaked at $4M in Q2 2024.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Dynamic Advisor Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.